S&P 500 7,365.46 â–ŧ 107.33 (-1.44%) DOW 51,666.84 â–ŧ 45.87 (-0.09%) NASDAQ 25,587.04 â–ŧ 579.56 (-2.21%) US Markets Closed â€ĸ 06:29 AM ET

GRDX

GridAI Technologies Corp.

Price Chart
Latest Quote

$4.60

-0.26 (-5.35%)
Current Price
Previous Close $4.86
Open $4.77
Day High $5.10
Day Low $4.60
Volume 16,568
Fetched: 2026-06-24T10:29:22
Stock Information
Shares Outstanding 6.66M
Sector Healthcare
Industry Biotechnology
Market Cap $30.65M
EPS (TTM) $-4.14
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
Insider Ownership8.29%
Institutional Ownership5.24%
Insider & Institutional transactions data not available
Valuation Ratios
Analyst Data
Recommendationnone
Technical Indicators
SMA20$5.54
SMA50$3.97
SMA200$3.47
RSI29.63
ATR0.6766
Short Float1.15%
Short Ratio0.50
Rel Volume0.13
Performance History
Week-5.35%
Month-0.22%
Quarter+118.01%
6 Months+129.43%
YTD-10.51%
Year+188.76%
3 Years-95.96%
5 Years-100.00%
10 Years-100.00%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-23 $4.60 16,600
2026-06-22 $4.86 158,800
2026-06-18 $5.40 181,400
2026-06-17 $4.95 73,900
2026-06-16 $5.09 76,800
2026-06-15 $4.86 207,800
2026-06-12 $5.27 80,800
2026-06-11 $5.90 35,600
2026-06-10 $5.79 69,100
2026-06-09 $6.37 84,600
2026-06-08 $6.22 40,900
2026-06-05 $6.35 121,300
2026-06-04 $6.06 35,000
2026-06-03 $5.93 96,200
2026-06-02 $6.47 121,200
2026-06-01 $6.80 504,500
2026-05-29 $5.61 235,700
2026-05-28 $4.95 284,800
2026-05-27 $4.74 39,800
2026-05-26 $4.61 129,000
About GridAI Technologies Corp.

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $693,683 $0 - -
Cost Of Revenue $693,683 $0 - -
Total Revenue $36,251 $0 $0 $0
Operating Revenue $36,251 $0 $0 $0
Expenses
Total Expenses $7,119,689 $15,621,274 $15,770,827 $12,678,066
Other Income Expense $934,257 $1,378 $-4,224 $-1,944,112
Other Non Operating Income Expenses $934,257 $1,378 $-4,224 $-232,741
Net Non Operating Interest Income Expense $-490,835 $875 $-19,932 $-7,464
Total Other Finance Cost $490,835 $-875 $19,932 -
Operating Expense $6,426,006 $15,621,274 $15,770,827 $12,678,066
General And Administrative Expense $5,500,524 $14,717,333 $10,737,609 $11,986,809
Interest Expense - - $22,463 $15,879
Interest Expense Non Operating - - $22,463 $15,879
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-6,080,356 $-15,619,021 $-15,794,983 $-14,629,642
Net Interest Income $-490,835 $875 $-19,932 $-7,464
Normalized Income $-6,080,356 $-15,619,021 $-15,794,983 $-12,918,271
Net Income From Continuing And Discontinued Operation $-6,392,654 $-18,059,336 $-15,794,983 $-14,629,642
Total Operating Income As Reported $-7,083,438 $-15,621,274 $-15,770,827 $-12,678,066
Net Income Common Stockholders $-6,729,894 $-18,300,301 $-16,103,111 $-14,973,069
Net Income $-6,392,654 $-18,059,336 $-15,794,983 $-14,629,642
Net Income Including Noncontrolling Interests $-6,553,578 $-18,059,336 $-15,794,983 $-14,629,642
Net Income Discontinuous Operations $-312,298 $-2,440,315 $0 -
Net Income Continuous Operations $-6,241,280 $-15,619,021 $-15,794,983 $-14,629,642
Pretax Income $-6,640,016 $-15,619,021 $-15,794,983 $-14,629,642
Operating Income $-7,083,438 $-15,621,274 $-15,770,827 $-12,678,066
Gross Profit $-657,432 $0 - -
Interest Income - - $2,531 $8,415
Special Income Charges - - $0 $-1,711,371
Interest Income Non Operating - - $2,531 $8,415
Per Share
Diluted EPS $-4.16 $-15.99 $-143.64 $-1250.82
Basic EPS $-4.16 $-15.99 $-143.64 $-1250.82
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-6,508,725 $-15,572,328 $-15,741,553 $-12,873,121
Reconciled Depreciation $574,713 $48,946 $29,274 $29,271
EBITDA (Bullshit earnings) $-6,508,725 $-15,572,328 $-15,741,553 $-14,584,492
EBIT $-7,083,438 $-15,621,274 $-15,770,827 $-14,613,763
Diluted Average Shares $1,616,705 $1,144,978 $112,113 $11,970
Basic Average Shares $1,616,705 $1,144,978 $112,113 $11,970
Diluted NI Availto Com Stockholders $-6,729,894 $-18,300,301 $-16,103,111 $-14,973,069
Preferred Stock Dividends $337,240 $240,965 $308,128 $296,127
Minority Interests $160,924 $0 - -
Tax Provision $-398,736 $0 - -
Research And Development $925,482 $903,941 $5,033,218 $691,257
Selling General And Administration $5,500,524 $14,717,333 $10,737,609 $11,986,809
Other Gand A $5,500,524 $14,717,333 $10,737,609 $11,986,809
Total Unusual Items - - $0 $-1,711,371
Total Unusual Items Excluding Goodwill - - $0 $-1,711,371
Otherunder Preferred Stock Dividend - - $0 $47,300
Gain On Sale Of Business - - $0 $-1,711,371
Impairment Of Capital Assets - - - $0
Fetched: 2026-06-23
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-22,248,470 $56,120,180 $1,918,747 $1,057,970
Total Assets $48,551,843 $85,409,506 $6,883,195 $5,439,699
Total Non Current Assets $45,955,963 $1,930,702 $1,926,959 $2,026,944
Non Current Prepaid Assets $0 $98,251 $11,250 $18,149
Goodwill And Other Intangible Assets $45,955,963 $1,684,182 $1,684,182 $1,684,182
Other Intangible Assets $21,837,287 - - -
Current Assets $2,595,879 $83,478,804 $4,956,236 $3,412,755
Other Current Assets $246,134 - - -
Assets Held For Sale Current $0 $83,170,009 $0 -
Prepaid Assets $110,934 $145,319 $1,244,466 $1,956,831
Receivables $1,339,027 $0 $0 $93,014
Other Receivables $1,309,053 - - $93,014
Accounts Receivable $29,974 $0 - -
Cash Cash Equivalents And Short Term Investments $899,784 $163,476 $3,711,770 $1,362,910
Cash And Cash Equivalents $899,784 $163,476 $3,711,770 $1,362,910
Other Non Current Assets - $21,516 $21,522 $21,513
Taxes Receivable - - - -
Debt
Net Debt $1,127,400 - - -
Total Debt $2,263,695 $140,534 $826,844 $883,705
Long Term Debt And Capital Lease Obligation $0 $59,024 $146,949 $214,060
Current Debt And Capital Lease Obligation $2,263,695 $81,510 $679,895 $669,645
Current Debt $2,027,184 - $612,784 $603,494
Liabilities
Total Liabilities Net Minority Interest $19,718,321 $27,605,144 $3,280,266 $2,697,547
Total Non Current Liabilities Net Minority Interest $4,559,000 $59,024 $146,949 $214,060
Non Current Deferred Liabilities $4,559,000 $0 - -
Non Current Deferred Taxes Liabilities $4,559,000 $0 - -
Current Liabilities $15,159,321 $27,546,120 $3,133,317 $2,483,487
Other Current Liabilities $14,870 $22,942,733 $4,239 $12,138
Current Deferred Liabilities $6,250,000 $0 - -
Current Notes Payable $2,027,184 $0 $612,784 $603,494
Payables And Accrued Expenses $6,630,756 $4,521,877 $2,449,183 $1,801,704
Interest Payable $111,000 $0 - -
Payables $5,296,832 $4,269,829 $1,623,893 $1,481,528
Dividends Payable $1,647,820 $1,310,581 $1,069,616 $761,488
Accounts Payable $3,381,500 $2,959,248 $554,277 $720,040
Tradeand Other Payables Non Current - - - $0
Other Non Current Liabilities - - - -
Other Payable - - - -
Equity
Common Stock Equity $19,816,863 $-3,876,738 $3,602,929 $2,742,152
Preferred Stock Equity $3,890,630 $61,681,100 - -
Total Equity Gross Minority Interest $28,833,522 $57,804,362 $3,602,929 $2,742,152
Stockholders Equity $23,707,493 $57,804,362 $3,602,929 $2,742,152
Gains Losses Not Affecting Retained Earnings $38,996 $0 - $0
Retained Earnings $-208,780,662 $-202,388,008 $-184,328,672 $-168,533,689
Other Equity Adjustments - - - -
Other
Ordinary Shares Number $4,224,145 $1,584,679 $520,332 $16,583
Share Issued $4,224,145 $1,584,679 $520,332 $16,583
Tangible Book Value $-26,139,100 $-5,560,920 $1,918,747 $1,057,970
Invested Capital $21,844,047 $-3,876,738 $4,215,713 $3,345,646
Working Capital $-12,563,442 $55,932,684 $1,822,919 $929,268
Capital Lease Obligations $236,511 $140,534 $214,060 $280,211
Total Capitalization $23,707,493 $57,804,362 $3,602,929 $2,742,152
Minority Interest $5,126,029 $0 - -
Foreign Currency Translation Adjustments $38,996 $0 - -
Additional Paid In Capital $228,558,107 $198,511,111 $187,931,445 $171,275,836
Capital Stock $3,891,052 $61,681,259 $156 $5
Common Stock $422 $159 $156 $5
Preferred Stock $3,890,630 $61,681,100 $0 $0
Long Term Capital Lease Obligation $0 $59,024 $146,949 $214,060
Current Capital Lease Obligation $236,511 $81,510 $67,111 $66,151
Current Accrued Expenses $1,333,924 $252,048 $825,290 $320,176
Dueto Related Parties Current $267,512 $0 - -
Goodwill $24,118,676 $1,684,182 $1,684,182 $1,684,182
Net PPE $0 $126,753 $210,005 $303,100
Accumulated Depreciation $-87,818 $-87,818 $-73,253 $-43,979
Gross PPE $87,818 $214,571 $283,258 $347,079
Leases $28,000 $28,000 $28,000 $28,000
Machinery Furniture Equipment $59,818 $59,818 $59,818 $59,818
Properties $0 $0 $0 $0
Line Of Credit - $0 $0 -
Other Properties - $126,753 $195,440 $259,261
Treasury Shares Number - - $0 -
Fetched: 2026-06-23
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-5,702,824 $-9,217,823 $-12,877,852 $-22,344,079
Operating Activities
Operating Cash Flow $-5,702,824 $-9,217,823 $-12,377,852 $-22,344,079
Cash Flow From Continuing Operating Activities $-5,702,824 $-9,217,823 $-12,377,852 $-22,344,079
Operating Gains Losses $-606,685 - - $1,711,371
Investing Activities
Investing Cash Flow $323,482 $88,169 $-500,000 $0
Cash Flow From Continuing Investing Activities $323,482 $88,169 $-500,000 $0
Capital Expenditure - - $-500,000 -
Financing Activities
Issuance Of Capital Stock $3,472,935 $6,225,891 $15,829,558 $23,247,303
Financing Cash Flow $5,889,383 $5,581,354 $15,226,721 $15,739,531
Cash Flow From Continuing Financing Activities $5,889,383 $5,581,354 $15,226,721 $15,739,531
Net Other Financing Charges $-750,000 - - $-6,914,955
Net Common Stock Issuance $3,472,935 $6,225,891 $15,829,558 $23,048,304
Common Stock Issuance $3,472,935 $6,225,891 $15,829,558 $23,048,304
Net Preferred Stock Issuance - - $0 $198,999
Preferred Stock Issuance - - $0 $198,999
Other
Repayment Of Debt $0 $-644,582 $-603,494 $-641,236
Issuance Of Debt $3,000,000 $0 - -
Interest Paid Supplemental Data $0 $36,165 $22,463 $15,879
End Cash Position $899,784 $184,992 $3,733,292 $1,384,423
Beginning Cash Position $184,992 $3,733,292 $1,384,423 $8,248,684
Effect Of Exchange Rate Changes $204,751 $0 $0 $-259,713
Changes In Cash $510,041 $-3,548,300 $2,348,869 $-6,604,548
Proceeds From Stock Option Exercised $166,448 $45 $657 $48,419
Net Issuance Payments Of Debt $3,000,000 $-644,582 $-603,494 $-641,236
Net Short Term Debt Issuance $0 $-644,582 $-603,494 $-641,236
Short Term Debt Payments $0 $-644,582 $-603,494 $-641,236
Net Long Term Debt Issuance $3,000,000 $0 - -
Long Term Debt Issuance $3,000,000 $0 - -
Net Business Purchase And Sale $323,482 $88,169 $0 -
Sale Of Business $323,482 $88,169 $0 -
Change In Working Capital $-344,232 $2,528,976 $2,190,363 $-10,501,629
Change In Other Working Capital $757,857 $109,401 $-7,899 -
Change In Other Current Liabilities $-4,925 $-77,137 $-66,151 $-111,596
Change In Payables And Accrued Expense $378,368 $1,484,566 $1,452,135 $-10,145,813
Change In Accrued Expense $-93,127 $-160,282 $1,617,898 $-73,077
Change In Payable $471,495 $1,644,848 $-165,763 $-10,072,736
Change In Account Payable $471,495 $1,644,848 $-165,763 $-1,987,691
Change In Prepaid Assets $143,724 $1,012,146 $719,264 $-151,206
Change In Receivables $-1,619,256 $0 $93,014 $-93,014
Changes In Account Receivables $-418,635 $0 - -
Other Non Cash Items $493,008 $5,632,036 $157,022 $277,426
Stock Based Compensation $733,950 $631,555 $1,040,472 $769,124
Depreciation Amortization Depletion $574,713 $48,946 $29,274 $29,271
Depreciation And Amortization $574,713 $48,946 $29,274 $29,271
Depreciation $574,713 $48,946 $29,274 $29,271
Gain Loss On Sale Of Business $-606,685 $0 - -
Net Income From Continuing Operations $-6,553,578 $-18,059,336 $-15,794,983 $-14,629,642
Net Intangibles Purchase And Sale - $0 $-500,000 $0
Purchase Of Intangibles - $0 $-500,000 $0
Net Foreign Currency Exchange Gain Loss - - $0 $1,711,371
Net PPE Purchase And Sale - - - $0
Purchase Of PPE - - - $0
Asset Impairment Charge - - - $0
Amortization Cash Flow - - - $0
Amortization Of Intangibles - - - $0
Gain Loss On Investment Securities - - - $200,490
Income Tax Paid Supplemental Data - - - -
Short Term Debt Issuance - - - -
Long Term Debt Payments - - - -
Sale Of PPE - - - -
Change In Other Current Assets - - - -
Fetched: 2026-06-23